Table 3.
Summary of the Incidence of Ocular AEs Across All References
| Adverse event | Number of references (of 22) citing AE |
|---|---|
| Blurred vision | 10 |
| Keratitis (including punctate) | 8 |
| Dry eye | 7 |
| Corneal microcysts/microcystic epithelial changes | 5 |
| Corneal deposits/inclusions | 4 |
| Conjunctivitis/keratoconjunctivitis | 3 |
| Decreased visual acuity | 2 |
| Unspecified keratopathy | 2 |
| Optic neuropathy | 2 |
| Eye irritation | 2 |
| Diplopia | 2 |
| Corneal epithelial defect/damage | 1 |
| Unspecified ocular toxicity | 1 |
| Ocular surface disease | 1 |
| Swollen tear duct | 1 |
| Increased lacrimation | 1 |
| Conjunctival hemorrhage | 1 |
| Eye redness | 1 |
| Ocular bleeding (location unspecified) | 1 |
| Uveitis (bilateral) | 1 |
| Iridocyclitis | 1 |
| Photophobia | 1 |
| Cataract | 1 |
| Cortical blindness | 1 |
| Scotoma | 1 |
| Nonspecific retinopathy | 1 |
| Eye pain | 1 |
| Floaters | 1 |
| Retinal vein occlusion | 1 |